Metraipolis › archive › dc_3cc915d702b2

Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety Study — Europe PMC PMID:40457975

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40457975
DOI
10.2174/011570159x361647250416072053
License (as archived)
solo-consultazione
Archived
2026-11-07T05:52:02.847Z
SHA-256 of the archived text
e1bad1ea8bba2bd85ba0b73c38f654c0a6b1e6fb30dd36bad4a7a149caeeba19
Stable URL of this page
https://metraipolis.com/documento/dc_3cc915d702b2

How to cite

Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety Study — Europe PMC PMID:40457975 — Europe PMC (en), https://europepmc.org/article/MED/40457975 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cc915d702b2 (Metraipolis archive dc_3cc915d702b2, sha256 e1bad1ea8bba2bd85ba0b73c38f654c0a6b1e6fb30dd36bad4a7a149caeeba19)
BibTeX
@misc{dc3cc915d702b2,
  title = {Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety Study — Europe PMC PMID:40457975},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40457975},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cc915d702b2; sha256 e1bad1ea8bba2bd85ba0b73c38f654c0a6b1e6fb30dd36bad4a7a149caeeba19},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40457975. Agents can read the archived copy with the MCP tool read_document.